Lynn P Freedman, Ronald J Waldman, Helen de Pinho, Meg E Wirth, A Mushtaque R Chowdhury, Allan Rosenfield
The Millennium Development Goals have become an international standard against which to assess trends in development and human well being.
In the early 1990s, a subset of the health sector— patented drugs—burst quite unexpectedly into the international trade debate. The ongoing trade negotiations of the Uruguay Round were in disarray, and support from sectors that relied on the protection of intellectual property rights became essential to move them forward.1 Indeed, the Uruguay Round Agreement was […]
